Relationships Among Health Insurance Literacy, Financial Toxicity, and Sociodemographic Factors in Patients With Cancer.


Journal

JCO oncology practice
ISSN: 2688-1535
Titre abrégé: JCO Oncol Pract
Pays: United States
ID NLM: 101758685

Informations de publication

Date de publication:
Oct 2023
Historique:
pmc-release: 01 10 2024
medline: 1 11 2023
pubmed: 24 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

The objective of the study was to describe the prevalence of health insurance literacy (HIL) and investigate how patient-reported outcome measures assessing HIL are related to financial toxicity in patients with cancer. We assessed HIL and financial toxicity in 404 patients enrolled between December 2019 and January 2021 at two medical centers in the United States. We conducted exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) to explore and test the relationships among the factors and items. We fit structural equation models (SEMs) to find the relationships among the factors and sociodemographic/clinical characteristics. The EFA revealed items loaded on four factors: knowledge about health insurance, confidence related to HIL (HIL confidence), information-seeking behavior related to health insurance, and financial toxicity. The four-factor CFA model had good fit statistics (comparative fit index, 0.960; Tucker-Lewis index, 0.958; root mean square error of approximation, 0.046; and standardized root mean square residual, 0.086). In SEM, income, education level, and race positively predicted knowledge about health insurance. Knowledge about health insurance and number of total lines of cancer treatment was positively associated with HIL confidence. Higher income, older age, and HIL confidence were associated with less financial toxicity. Higher levels of financial toxicity, HIL confidence, and knowledge were associated with greater information-seeking behavior. Our findings showed how different aspects of HIL are related to financial toxicity even after adjustment for sociodemographic and clinical characteristics. Future studies should investigate the longitudinal relationships among these factors to help develop interventions to mitigate financial toxicity.

Identifiants

pubmed: 37616546
doi: 10.1200/OP.22.00829
pmc: PMC10615437
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

888-898

Références

JCO Oncol Pract. 2020 Jun;16(6):e529-e537
pubmed: 32048931
J Clin Oncol. 2016 Mar 20;34(9):980-6
pubmed: 26811521
Am J Transplant. 2010 Oct;10(10):2208-14
pubmed: 20931694
Cancer. 2019 May 15;125(10):1737-1747
pubmed: 30663039
J Natl Cancer Inst. 2015 Dec 11;108(5):
pubmed: 26657334
Expert Rev Pharmacoecon Outcomes Res. 2018 Oct;18(5):505-517
pubmed: 29869568
Cancer. 2014 Oct 15;120(20):3245-53
pubmed: 24954526
Am J Med. 2018 Oct;131(10):1187-1199.e5
pubmed: 29906429
J Aging Health. 2020 Jun/Jul;32(5-6):394-400
pubmed: 30698482
Int J Environ Res Public Health. 2020 Aug 12;17(16):
pubmed: 32806743
Support Care Cancer. 2020 Sep;28(9):4255-4262
pubmed: 31900612
J Natl Cancer Inst. 2016 Oct 20;109(2):
pubmed: 27754926
J Health Commun. 2014;19 Suppl 2:225-39
pubmed: 25315595
Support Care Cancer. 2021 Oct;29(10):5673-5680
pubmed: 33594514
CA Cancer J Clin. 2022 Sep;72(5):437-453
pubmed: 35584404
JAMA Netw Open. 2022 Jul 1;5(7):e2223141
pubmed: 35877122
Transl Behav Med. 2021 Jun 17;11(6):1289-1291
pubmed: 32815543
Am J Obstet Gynecol. 2022 Jun;226(6):817.e1-817.e9
pubmed: 34902319
J Surg Oncol. 2019 Jul;120(1):85-92
pubmed: 30650186
J Gen Intern Med. 2019 Aug;34(8):1494-1502
pubmed: 31044413
JAMA Intern Med. 2021 Feb 1;181(2):162-167
pubmed: 33165499
J Med Econ. 2013 Oct;16(10):1169-78
pubmed: 23866016
J Oncol Pract. 2015 May;11(3):171-3
pubmed: 25829522
Cancer. 2017 Nov 1;123(21):4092-4096
pubmed: 28817185

Auteurs

Minji K Lee (MK)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.

Urshila Durani (U)

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

Nan Zhang (N)

Department of Quantitative Health Sciences, Mayo Clinic, Phoenix, AZ.

Talal Hilal (T)

Department of Quantitative Health Sciences, Mayo Clinic, Phoenix, AZ.
Division of Hematology/Oncology, University of Mississippi, Jackson, MS.

Rahma M Warsame (RM)

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

Bijan Borah (B)

Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
Division of Health Care Delivery Research, Mayo Clinic, Rochester, MN.

Nandita Khera (N)

Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ.

Joan M Griffin (JM)

Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
Division of Health Care Delivery Research, Mayo Clinic, Rochester, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH